Last reviewed · How we verify
NCT03451669: Infrared Shunt
Thermal Camera Detection of Ventriculoperitoneal Shunt Flow
trial in Hydrocephalus in 2 participants. Completed in 2 December 2019.
30 November 2019
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2 |
| Start date | 16 April 2018 |
| Primary completion | 30 November 2019 |
| Estimated completion | 2 December 2019 |
| Sites | 1 location across United States |
Conditions studied
- Hydrocephalus — all drugs for Hydrocephalus →
Sponsor
University of Pennsylvania
Who can join
18 and older, any sex, with Hydrocephalus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There have been reports in the past of using thermal cameras to demonstrate flow in the tubing as a surrogate of proper shunt function. This was shown to have almost 90% accuracy at determining proper functioning but required expensive equipment that was not universally available. There is now smart phone based thermal camera technology (Flir One: http://www.flir.com/flirone/) that could make this technique widely available for health care use. The goal of the study is to determine if this device can demonstrate flow in the distal tubing of a VP shunt.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Current State of Clinical Trials Studying Hydrocephalus: An Analysis of ClinicalTrials.gov.
Abraham ME, Povolotskiy R, Gold J, Ward M, et al · · 2020 · cited 3× · PMID 32983722 · DOI 10.7759/cureus.10029
Verify or expand the search:
- PubMed search for NCT03451669
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hydrocephalus
Currently open trials in the same condition.
- NCT07478926 — Flow Detection in Open and Closed Shunt Valve Periods · NA · recruiting
- NCT07442929 — Crystallization of LA and Adjuvant Mixtures in Cerebrospinal Fluid · recruiting
- NCT06797219 — Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4 · NA · recruiting
- NCT07380477 — VentricuLostomy AssoCiaTed InfeCtions (LACTIC): Focus on CSF Lactate and Sampling Site · recruiting
- NCT06276543 — Bactiseal Catheter Safety Registry Study · recruiting
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03451669 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 11 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03451669.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing